APASOMICS

Apasomics is a biotechnology company developing innovative apasome-based drug delivery systems to transform the treatment of bone diseases. Our nanocarriers deliver bisphosphonates directly to the bone, effectively inhibiting osteoclast activity to prevent bone loss while potentially promoting bone regeneration. By combining nanotechnology, precision medicine, and advanced drug delivery, we are creating next-generation therapeutics for osteoporosis, and skeletal disorders—enhancing efficacy, reducing side effects, and improving patient outcomes.